Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation

Zefeng Wang; Liting Cheng; Junmeng Zhang; Zhuo Liang; Ruiqing Dong; Fei Hang; Xinlu Wang; Ziyu Wang; Yongquan Wu; Jie Du

doi:10.12659/MSM.926221

08 September 2020 : Clinical Research

Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation

Zefeng Wang^1ACDE, Liting Cheng^1BCD, Junmeng Zhang^1AD, Zhuo Liang^1CD, Ruiqing Dong^2B, Fei Hang^1B, Xinlu Wang^1B, Ziyu Wang^1B, Yongquan Wu^1AD*, Jie Du^3ADE

DOI: 10.12659/MSM.926221

Med Sci Monit 2020; 26:e926221

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Grouped according to the size of the LA LVZ. Group A: patients with few or even none LVZ (A) and LA LVZ less than 20% (B). Group B: patients with LVZ greater than 20% (C).

Back to the Article

Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation

Your Privacy